BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36103990)

  • 1. Comparison of time trends in the incidence of primary liver cancer between China and the United States: an age-period-cohort analysis of the Global Burden of Disease 2019.
    Zou Z; Zhang Z; Lu C; Wang H
    Chin Med J (Engl); 2022 Sep; 135(17):2035-2042. PubMed ID: 36103990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.
    Liu Z; Mao X; Jiang Y; Cai N; Jin L; Zhang T; Chen X
    Cancer Med; 2019 Sep; 8(12):5787-5799. PubMed ID: 31385465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: A DALY-based analysis of the Global Burden of Disease 2019 study.
    Choi S; Kim BK; Yon DK; Lee SW; Lee HG; Chang HH; Park S; Koyanagi A; Jacob L; Dragioti E; Radua J; Shin JI; Kim SU; Smith L
    Clin Mol Hepatol; 2023 Apr; 29(2):433-452. PubMed ID: 36597018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.
    Huang DQ; Singal AG; Kono Y; Tan DJH; El-Serag HB; Loomba R
    Cell Metab; 2022 Jul; 34(7):969-977.e2. PubMed ID: 35793659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Trends of Liver Cancer Incidence and Mortality in China 1990-2017: A Joinpoint and Age-Period-Cohort Analysis.
    Wang F; Mubarik S; Zhang Y; Wang L; Wang Y; Yu C; Li H
    Int J Environ Res Public Health; 2019 Aug; 16(16):. PubMed ID: 31408961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH.
    Tan DJH; Setiawan VW; Ng CH; Lim WH; Muthiah MD; Tan EX; Dan YY; Roberts LR; Loomba R; Huang DQ
    Hepatology; 2023 Apr; 77(4):1150-1163. PubMed ID: 36037274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019.
    Chen H; Zhan Y; Zhang J; Cheng S; Zhou Y; Chen L; Zeng Z
    JMIR Public Health Surveill; 2022 Dec; 8(12):e34809. PubMed ID: 36508249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term trends in incidence, mortality and burden of liver cancer due to specific etiologies in Hubei Province.
    Liu H; Li J; Zhu S; Zhang X; Zhang F; Zhang X; Zhao G; Zhu W; Zhou F
    Sci Rep; 2024 Feb; 14(1):4924. PubMed ID: 38418596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.
    Liu Z; Jiang Y; Yuan H; Fang Q; Cai N; Suo C; Jin L; Zhang T; Chen X
    J Hepatol; 2019 Apr; 70(4):674-683. PubMed ID: 30543829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia burden comparison between China and United States based on the Global Burden of Disease Study 2019.
    Liu D; Li C; Li Y; Zhou L; Li J; Wang Y; Wan X; Zhou L; Wang L
    World J Urol; 2023 Dec; 41(12):3629-3634. PubMed ID: 37831157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019.
    Liu Y; Zheng J; Hao J; Wang RR; Liu X; Gu P; Yu H; Yu Y; Wu C; Ou B; Peng Z
    Cancer Med; 2022 Mar; 11(5):1310-1323. PubMed ID: 35118819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
    Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
    Kim D; Li AA; Gadiparthi C; Khan MA; Cholankeril G; Glenn JS; Ahmed A
    Gastroenterology; 2018 Oct; 155(4):1154-1163.e3. PubMed ID: 30009816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Long-Term Trend Study of Tuberculosis Incidence in China, India and United States 1992-2017: A Joinpoint and Age-Period-Cohort Analysis.
    Cui Y; Shen H; Wang F; Wen H; Zeng Z; Wang Y; Yu C
    Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32403353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tendency analysis of incidence and mortality of mechanical injuries among Chinese residents from 1990 to 2019].
    Liu T; Yang Z; Li F; Li Y; Liu X; Wu Z; Cao C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Oct; 34(10):1082-1087. PubMed ID: 36473568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in migraine incidence among women of childbearing age from 1990 to 2019 and the prediction for 2030: an analysis of national data in China.
    Fan Z; Kang J; Li W; Wang Z; Qiao H; Xu F
    J Headache Pain; 2023 Nov; 24(1):158. PubMed ID: 38008771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attributable causes of liver cancer mortality and incidence in china.
    Fan JH; Wang JB; Jiang Y; Xiang W; Liang H; Wei WQ; Qiao YL; Boffetta P
    Asian Pac J Cancer Prev; 2013; 14(12):7251-6. PubMed ID: 24460283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Changes of HIV/AIDS Incidence Rate in China and the U.S. Population From 1994 to 2019: A Join-Point and Age-Period-Cohort Analysis.
    Ma Y; Cui Y; Hu Q; Mubarik S; Yang D; Jiang Y; Yao Y; Yu C
    Front Public Health; 2021; 9():652868. PubMed ID: 34869132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time Trends in the Incidence of Spinal Pain in China, 1990 to 2019 and Its Prediction to 2030: The Global Burden of Disease Study 2019.
    Wei J; Chen L; Huang S; Li Y; Zheng J; Cheng Z; Xie Z
    Pain Ther; 2022 Dec; 11(4):1245-1266. PubMed ID: 35969366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
    Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
    J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.